EXPO vs ACA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 15, 2026
EXPO
ACA
Investment Advisor Scores
ACA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EXPO | ACA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 29.3255 | 36.1011 | EXPO |
| PEG Ratio | 2.0325 | 2.2544 | EXPO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 10.5% | 4.4% | EXPO |
| Earnings Growth | 13.5% | 57.8% | ACA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 59.2/100 | 50.5/100 | EXPO |
| Profit Margin | 19.8% | 7.7% | EXPO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EXPO
MarkupPrice above SMA50, rising 50-day trend (0.9% over 20 days), RSI 68
ACA
MarkupPrice above SMA50, rising 50-day trend (6.4% over 20 days), RSI 67
Fundamentals Snapshot
| Metric | EXPO | ACA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 24.8 | 28.6 |
| Trailing P/E | 30.0 | 32.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.4% | 0.2% |
| Operating Margin | 0.2% | 0.1% |
| EPS | 2.23 | 4.47 |
| Dividend Yield | 0.02% | 0.00% |